On World #EnvironmentDay, we are proud to celebrate the recognition of an exceptional heritage. 🌿
The Terres d’Hérault territory has officially been designated a UNESCO Global Geopark! At its heart, the Avène Impluvium and its thermal hydrosystem have been identified as a geosite of interest, reflecting a rare meeting point between geology, hydrogeology and health.
For more than 50 years, Eau Thermale Avène has placed water understanding and preservation at the core of its scientific and environmental commitment. Through its Water Laboratory and ongoing research, our brand continues to advance knowledge while protecting this exceptional ecosystem.
🔬 More than 150 clinical studies dedicated to Avène Thermal Spring Water
🌿 A rare thermal hydrosystem recognized within the UNESCO Global Geopark network
👩 Around 2000 spa patients welcomed each year at Centre Thermal Avène.
This recognition strengthens the collective work led with API’A and local stakeholders to preserve and promote this territory for future generations 🤝
#PierreFabre #NewWaysToCare #Avène #UNESCO
[Inside the Lab] 🔬For us, a respectful work environment has to encourage professional development and personal growth. For this second interview, we invited Maud Valenta and Nicolas Rolly to share their perspectives on mobility at Pierre Fabre 💬
#PierreFabre#NewWaysToCare #WeCareMovement
[Brands that Care] 🔬From scalp disorders to acne, hyperpigmentation, or hair loss, Ducray has been advancing research to better understand the real impact of skin conditions and develop new active ingredients to address them. #PierreFabre#NewWaysToCare
On Wednesday, Laboratoires Pierre Fabre announced a strategic investment of nearly €50m to transform and expand its Avène plant, a historic industrial site entirely dedicated to manufacturing and packaging Eau Thermale Avène products. 🚀
This major project will both double the site’s production capacity by 2029 – from 100 to 200 million units per year – and accelerate the transformation of Laboratoires Pierre Fabre’s industrial network towards next-generation factories : more modern, more automated and more resource-efficient.
Avène, Laboratoires Pierre Fabre’s leading brand and the world’s No. 2 dermo-cosmetics brand, is experiencing strong international growth, particularly in China (+10.7%) and the United States (+9.2%). This investment will enable the Group to keep pace with this momentum and better serve patients and consumers worldwide.
This €50 million investment, equivalent to the Group’s usual annual industrial CAPEX across all its sites, underlines the strategic importance of Avène within Pierre Fabre’s industrial footprint.
Beyond industrial performance, Laboratoires Pierre Fabre is reaffirming its commitment to producing mainly in France, while accelerating its efforts in industrial innovation and environmental transition: more efficient facilities, lower energy consumption and a reduced environmental footprint.🌿💡
Discover the full press release 👉 https://t.co/H85pgX12Fo
#PierreFabre #NewWaysToCare #Avène #Innovation
[Inno 360°] More exposed to triggers like cold or pollution, facial skin reacts immediately and more intensely. With EXOMEGA FACE CARE, A-DERMA leverages its expertise in dermo-proteomics to act at the source of skin imbalance. #NewWaysToCare#PierreFabre
Chicago takes center stage this May for #ASCO26 the world’s most important gathering dedicated to advancing cancer research and care.
Laboratoires Pierre Fabre is proud to take part in the American Society of Clinical Oncology (ASCO)Annual Meeting 2026 (May 29 – June 2), where experts from around the globe come together to share the latest scientific breakthroughs and progress in oncology.
At Laboratoires Pierre Fabre, we are committed to developing more personalized, mutation-specific treatments through science, collaboration, and innovation, always with patients at the center.
Follow Pierre Fabre Oncology to Know more!
#PierreFabre #ASCO26 #TargetedTherapy #Oncology #Healthcare #Innovation #breastcancer #nsclc #colorectalcancer #melanoma #PTLD
🎉 We are pleased to announce the appointment of Herve Hoppenot as Chairman of the Board of Pierre Fabre SA.
This appointment was approved by the Board of Directors at its meeting on 21 May, following a proposal from Pierre Fabre Participations, the Group’s controlling holding company.
Member of the Board of Directors since January 2024, Hervé Hoppenot succeeds Roch Doliveux, now Vice-Chairman of the Board of Directors.
With an international career in the health and biotechnology sector, notably at the head of Incyte and previously of Novartis' global oncology franchise, Hervé Hoppenot will bring his expertise to the development of Laboratoires Pierre Fabre, especially in the field of oncology.
“I am very pleased to bring my expertise to an independent group that is deeply rooted in its local community and a major player in the health and beauty sector. It is an honor for me to assist the group’s CEO, Eric Ducournau, in growing the business as he has been doing since 2019, and to contribute to the development of a highly ethical group, owned by a government-recognized public-interest foundation, which receives the profits distributed by the company to develop programs that benefit those most in need of healthcare in the least developed countries .” - Hervé Hoppenot
This appointment marks a new stage in the ambition of Pierre Fabre SA to continue its development in the service of patients and consumers, while remaining faithful to its founding values.
#PierreFabre #NewWaysToCare
[Inno 360°] ULTRA SERUM SPF50+, by #Avène, combines the most advanced sun technology, including the patented TRIASORB™ filter, with the targeted performance of skincare, in an ultra-light texture that may be applied at the start of any routine. #PierreFabre#NewWaystoCare
[Inno 360°] Introducing our new platform dedicated to dermo-cosmetic clinical studies. 🔬This website brings together a selection of clinical studies, providing clear and accessible insights into the safety and efficacy of our dermo-cosmetic products. #PierreFabre#NewWaystoCare
👉 https://t.co/CsTxdQ8Qw1
[Inside the Lab] 🎤 Marine Saintobert and Thomas Bègue share their take on internal mobility at Laboratoires Pierre Fabre. Are you ready to join the We Care Movement? Explore opportunities here: https://t.co/uN2Z9cb23j #PierreFabre#NewWaysToCare
[Numbers that Matter] Through our RUSCUS plan, employees can actively contribute to the development of Laboratoires #PierreFabre and benefit from its growth. 📊Our unique model ensures a fair sharing of the value created and reflects a collective commitment to preserving it. #NewWaysToCare
Bonjour,
La production de notre médicament Tanganil se poursuit normalement.
Si vous avez des difficultés à en trouver, nous vous conseillons de contacter une autre pharmacie, qui pourra peut-être vous le fournir plus rapidement.
Prenez soin de vous 💙
Les Laboratoires Pierre Fabre 🌿
Laboratoires Pierre Fabre are proud to participate in the 22nd edition of the EADO Congress, which will be held in Prague, Czech Republic, from April 23 to 25, 2026, as a Gold Sponsor.📍 Meet us at Congress O2 Universum, stand no. 20.
This major European event in dermato-oncology brings together leading experts to share the latest scientific advances and foster collaboration in the fight against skin cancers.
During the congress, Laboratoires Pierre Fabre will participate in two scientific symposia that will bring together international experts in patient care from around the world.
In 2025, 89% of our pharma investments were dedicated to R&D, supporting the development of targeted therapies and strengthening our oncology pipeline, with several molecules currently in clinical and pre-clinical development. 🔬
As Key player in oncology and rare diseases, we continue to innovate to address unmet medical needs and improve patient outcomes.
#PierreFabre #NewWaysToCare #EADO #Oncology #Innovation #RareDiseases
Last week, Laboratoires Pierre Fabre gathered their teams in Toulouse for the 2026 International Convention.
This event brought together our pharma, business and marketing teams from around the world. A total of 1,291 employees from 41 countries took part in this edition, in a hybrid format designed to foster international collaboration 🌍
Across the 12 sessions, this Convention helped align our priorities and reinforce a shared vision around our three franchises: Primary Care, Dermatology, and Oncology. Our dermo-cosmetic brands, such as Avène, Ducray, Klorane, René Furterer, A-Derma and Oral Care, were also prominently featured throughout the week.
This edition further strengthened our collective momentum and commitment to developing innovative, science-based solutions for patients and consumers worldwide.
A warm thank you to all the teams whose dedication made this edition a success. 🤝
Eric Ducournau Marie-Andrée Gamache Maud Vimeux Anne Laure Nguyen Huy Lai Nuria Perez Cullell Eric Gouy Fernando Junoy Vincent Huraux
#PierreFabre #NewWaysToCare #Innovation #Healthcare
[Numbers that Matter] Do you know our care areas? 🔬 With over 2,800 patents and applications across Dermo-Cosmetics and Medical Care, our commitment to R&D is stronger than ever. #PierreFabre#NewWaysToCare